Indore Hospitals Practice Blackout Drill, Ready for Mass Casualties

IMT News Desk
IMT News Desk
· 2 min read
Team of doctors taking pregnant woman to operation theatre in the hospital

Over 250 hospitals in Indore switched off lights, displayed red cross signs, and mapped mass‑casualty plans during a 12‑minute blackout drill.

As dusk fell over Indore, hospital rooftops went dark and red cross signs came alive across 253 government and private healthcare facilities. Chief Medical and Health Officer Dr BS Setiya had called on every hospital to cover external lights and hang curtains over windows for a 12‑minute blackout exercise. Inside, lamps glowed softly, ensuring patient care continued even as the city outside plunged into simulated emergency conditions.

Dr Setiya explained that the drill served two purposes: to test blackout procedures and to ensure hospitals were ready for sudden surges of injured patients. “We approached all the hospital officials to follow the instructions of installing red cross signs that should be well visible,” he said, noting that no light was to show outside but that medical services would run uninterrupted indoors.

During the exercise, hospital administrators activated their mass‑casualty protocols. Staff practiced rapid triage setups in corridors and mapped routes from entrances to emergency wards, ready to receive large numbers of patients at once. Ambulance bays remained clear, and standby teams assembled in makeshift command centres. By the end of the blackout drill, each hospital confirmed that its external blackout, internal lighting, and casualty‑management plans had worked seamlessly.

Dr Setiya praised the hospitals’ swift compliance. He said that this coordinated drill offered vital insights into logistical hurdles and staff readiness. As India’s urban centres face growing risks—from industrial accidents to natural disasters—such city‑wide exercises help hospitals sharpen their emergency response, ensuring that when real crises strike, care continues without a flicker.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk